Aug. 10 at 3:54 PM
$CRH at short term support line. Strong Q2 2026 results driven by pricing momentum. The company is positioned for
$8.5B in adjusted EBITDA, w/ EPS of
$6.05. The 100% cash acquisition of Arcosa adds another +
$700M in annual EBITDA. Raising the DCF outlook with an implied valued of
$100 p/s. This would support further speculation and drive share price to higher levels